|Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association|
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
|Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association|
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
Circulation 131 (4), 434-441, 2015
|Heart disease and stroke statistics—2017 update|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
|2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology …|
SD Fihn, JM Gardin, J Abrams, K Berra, JC Blankenship, AP Dallas, ...
Journal of the American College of Cardiology 60 (24), e44-e164, 2012
|Diuretic strategies in patients with acute decompensated heart failure|
GM Felker, KL Lee, DA Bull, MM Redfield, LW Stevenson, SR Goldsmith, ...
New England Journal of Medicine 364 (9), 797-805, 2011
|Effect of nesiritide in patients with acute decompensated heart failure|
CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ...
N Engl J Med 365, 32-43, 2011
|Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay|
SG Franzblau, RS Witzig, JC McLaughlin, P Torres, G Madico, ...
Journal of clinical microbiology 36 (2), 362-366, 1998
|Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes|
RR Holman, MA Bethel, RJ Mentz, VP Thompson, Y Lokhnygina, JB Buse, ...
New England Journal of Medicine 377 (13), 1228-1239, 2017
|Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure|
AF Hernandez, MA Greiner, GC Fonarow, BG Hammill, PA Heidenreich, ...
Jama 303 (17), 1716-1722, 2010
|Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial|
MM Redfield, HH Chen, BA Borlaug, MJ Semigran, KL Lee, G Lewis, ...
Jama 309 (12), 1268-1277, 2013
|2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: Developed in collaboration with the American Heart Association, American Society of …|
DR Holmes Jr, MJ Mack, S Kaul, A Agnihotri, KP Alexander, SR Bailey, ...
Catheterization and Cardiovascular Interventions 79 (7), 1023-1082, 2012
|Ultrafiltration in decompensated heart failure with cardiorenal syndrome|
BA Bart, SR Goldsmith, KL Lee, MM Givertz, CM O'Connor, DA Bull, ...
New England Journal of Medicine 367 (24), 2296-2304, 2012
|Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke|
JL Saver, GC Fonarow, EE Smith, MJ Reeves, MV Grau-Sepulveda, ...
Jama 309 (23), 2480-2488, 2013
|Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times …|
GC Fonarow, EE Smith, JL Saver, MJ Reeves, DL Bhatt, ...
circulation 123 (7), 750-758, 2011
|Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling|
P Sanchez, AM Hernández, B Stecca, AJ Kahler, AM DeGueme, A Barrett, ...
Proceedings of the National Academy of Sciences 101 (34), 12561-12566, 2004
|Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes|
BA Steinberg, X Zhao, PA Heidenreich, ED Peterson, DL Bhatt, ...
Circulation 126 (1), 65-75, 2012
H Jneid, GC Fonarow, CP Cannon, AF Hernandez, IF Palacios, AO Maree, ...
Circulation 118 (25), 2803-2810, 2008
|Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial|
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino Sr, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
|Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction|
BE Strauer, M Brehm, T Zeus, N Gattermann, A Hernandez, RV Sorg, ...
Deutsche medizinische Wochenschrift (1946) 126 (34-35), 932-938, 2001
|Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative|
GC Fonarow, X Zhao, EE Smith, JL Saver, MJ Reeves, DL Bhatt, Y Xian, ...
Jama 311 (16), 1632-1640, 2014